Ads
related to: novartis stock price
Search results
Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com
Investing.com· 3 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed as...
SageView Advisory Group LLC Acquires 718 Shares of Novartis AG (NYSE:NVS)
ETF DAILY NEWS· 5 days agoSageView Advisory Group LLC boosted its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 30.6% in the fourth quarter, according to the company in its most recent ...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoShares of the three pharma giants closed 1% higher. (helena.smolak@wsj.com) 1133 ...Swiss pharmaceutical company could start to pick up next year, but...
‘I’m a stuntman with no pension – should I sell four of my Lamborghinis and buy gold?’
The Telegraph via Yahoo Finance· 7 hours agoA physical gold ETF is a listed instrument that owns physical gold and participates in the price...
Asahi Kasei to Buy Swedish Biotech for Rare Disease Drug
Bloomberg via Yahoo Finance· 5 days ago(Bloomberg) -- Japanese industrial group Asahi Kasei Corp. plans to buy Swedish biotechnology firm...
Why Is Lilly (LLY) Up 4.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 days agoPerformance of an Industry Player Lilly belongs to the Zacks Large Cap Pharmaceuticals industry....
PayPal upgraded, UiPath downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 2 days agoGoldman Sachs initiated coverage of Medtronic (MDT) with a Sell rating and $83 price target. While...
Here are Thursday's biggest analyst calls: Apple, Nvidia, Salesforce, Amazon, Okta, Eli Lilly, Cava,...
CNBC· 2 days ago"Our top structural long: UnitedHealth Group (UNH - $597 price target; +20% upside) as the most...
Verve Therapeutics appoints new Chief Scientific Officer By Investing.com
Investing.com· 1 day agoVerve Therapeutics, a biotechnology firm focused on gene editing treatments for cardiovascular...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 3 days agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...
